- Home
- TERN vs FCT Comparison
TERN vs FCT Comparison
Compare TERN & FCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- FCT
- Stock Information
- Founded
- TERN 2017
- FCT 2004
- Country
- TERN United States
- FCT United States
- Employees
- TERN N/A
- FCT N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- FCT Finance Companies
- Sector
- TERN Health Care
- FCT Finance
- Exchange
- TERN Nasdaq
- FCT Nasdaq
- Market Cap
- TERN 262.9M
- FCT 255.2M
- IPO Year
- TERN 2021
- FCT N/A
- Fundamental
- Price
- TERN $3.54
- FCT $9.80
- Analyst Decision
- TERN Buy
- FCT
- Analyst Count
- TERN 5
- FCT 0
- Target Price
- TERN $15.63
- FCT N/A
- AVG Volume (30 Days)
- TERN 692.5K
- FCT 106.8K
- Earning Date
- TERN 05-08-2025
- FCT 01-01-0001
- Dividend Yield
- TERN N/A
- FCT 11.29%
- EPS Growth
- TERN N/A
- FCT N/A
- EPS
- TERN N/A
- FCT N/A
- Revenue
- TERN N/A
- FCT N/A
- Revenue This Year
- TERN N/A
- FCT N/A
- Revenue Next Year
- TERN N/A
- FCT N/A
- P/E Ratio
- TERN N/A
- FCT N/A
- Revenue Growth
- TERN N/A
- FCT N/A
- 52 Week Low
- TERN $1.87
- FCT $9.45
- 52 Week High
- TERN $11.40
- FCT $10.42
- Technical
- Relative Strength Index (RSI)
- TERN 67.52
- FCT 41.57
- Support Level
- TERN $3.01
- FCT $9.76
- Resistance Level
- TERN $3.60
- FCT $9.93
- Average True Range (ATR)
- TERN 0.21
- FCT 0.07
- MACD
- TERN 0.06
- FCT -0.01
- Stochastic Oscillator
- TERN 91.33
- FCT 16.67
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest
First Trust Senior Floating Rate Income Fund II is the United States based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, the fund attempts to preserve capital. The fund seeks to achieve the objectives by investing in a portfolio of senior floating-rate loan interests. Its portfolio of investments consists of aerospace and defense, agricultural products, broadcasting, cable and satellite, electric utilities and other sectors.